Stephen J Galli - Net Worth and Insider Trading

Stephen J Galli Net Worth

The estimated net worth of Stephen J Galli is at least $147 dollars as of 2024-11-13. Stephen J Galli is the Director of Atossa Therapeutics Inc and owns about 98 shares of Atossa Therapeutics Inc (ATOS) stock worth over $147. Details can be seen in Stephen J Galli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen J Galli has not made any transactions after 2012-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stephen J Galli

To

Stephen J Galli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen J Galli owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .

Click here to see the complete history of Stephen J Galli’s form 4 insider trades.

Insider Ownership Summary of Stephen J Galli

Ticker Comapny Transaction Date Type of Owner
ATOS Atossa Therapeutics Inc 2012-11-07 director

Stephen J Galli Latest Holdings Summary

Stephen J Galli currently owns a total of 1 stock. Stephen J Galli owns 98 shares of Atossa Therapeutics Inc (ATOS) as of November 7, 2012, with a value of $147.

Latest Holdings of Stephen J Galli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATOS Atossa Therapeutics Inc 2012-11-07 98 1.50 147

Holding Weightings of Stephen J Galli


Stephen J Galli Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen J Galli has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the sale of 0 shares on November 7, 2012, which brought Stephen J Galli around $0.

Insider Trading History of Stephen J Galli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen J Galli Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen J Galli Ownership Network

Ownership Network List of Stephen J Galli

No Data

Ownership Network Relation of Stephen J Galli

Insider Network Chart

Stephen J Galli Owned Company Details

What does Atossa Therapeutics Inc do?

Who are the key executives at Atossa Therapeutics Inc?

Stephen J Galli is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .

Atossa Therapeutics Inc (ATOS) Insider Trades Summary

Over the past 18 months, Stephen J Galli made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .

In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.

Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atossa Therapeutics Inc Insider Transactions

No Available Data

Stephen J Galli Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen J Galli. You might contact Stephen J Galli via mailing address: C/o Atossa Genetics, Inc., 4105 Madison Street, Suite 320, Seattle Wa 98112.